Redbock - an NES Fircroft company ยท 1 day ago
Clinical Trial Liaison
Redbock, an NES Fircroft company, is an innovative biotechnology company based in Massachusetts seeking a Clinical Trial Liaison. The role focuses on providing clinical trial execution, compliance, and site interface and communication support, with significant travel involved.
Responsibilities
Serve as sponsor contact for study sites and provide site training and education regarding study protocol, disease state, trial conduct, etc., and provide timely responses to related operational and technical questions
Support pre-study feasibility assessment, study startup, enrollment, and compliance activities
Grow and develop network of investigators and Key Opinion Leaders (KOLs)
Team meetings and communications, reporting, and both remote and in-person study site visits
Other duties, as required
Qualification
Required
6 years of relevant clinical operations experience including solid sponsor-side experience liaising with study sites and collaborating and driving trial enrollment, execution and compliance
Solid experience with respiratory trials, including understanding of pulmonary testing, including FeNO and spirometry
Experience as an MSL, Clinical Trial Educator, Clinical Trial Liaison, Nurse, Nurse Practitioner, Physician Assistant, and/or physician
Proven skills and experience building and managing relationships with investigators, other researchers, healthcare professionals, KOLs, and internal staff members across geographical borders
Excellent written and verbal English and interpersonal communication skills, and computer skills including Microsoft Office and standard clinical systems such as CTMS, EDC, eTMF and IRT
Preferred
Relevant Bachelor's degree: Clinical, Healthcare or Scientific emphasis strongly preferred
bi-lingual is a big plus
Company
Redbock - an NES Fircroft company
Redbock is a consultancy that delivers customized resourcing solutions to pharmaceutical, biotechnology, medical device and diagnostics companies.
Funding
Current Stage
Growth StageTotal Funding
unknown2018-06-20Acquired
Company data provided by crunchbase